Download Your Copy of the Agenda
The 9th Antigen-Specific Immune Tolerance Summit is your unique forum to learn, network and partner with the brightest minds revolutionizing the antigen-specific immune tolerance industry.
The only end-to-end meeting dedicated to advancing antigen-specific immune tolerance.
Fresh data from leading programs including DIAGNODE-3 in T1D from Diamyd, COUR’s PBC & MG updates, Topas Therapeutics’ celiac disease learnings and developments.
Explore innovations in mRNA-LNP delivery, next-generation Treg and gene-edited cell therapies, and so much more.
Highly applied discussions on trial design, potency assays, scaling cell therapy manufacturing, and regulatory expectations.
Benchmark emerging modalities, share real-world clinical insights, and shape the next wave of targeted, durable, tolerance-inducing therapies.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.